Universal reference book for medicines
Name of the preparation: PASSIFIT ® (PASSIFIT)

Active substance: comb.
drug
Type: Phytomedication with sedative effect

Manufacturer: ФАРМСТАНСТАНАР-ЛЕКСРЕДСТВА (Russia)
Composition, form of production and packaging
?
Syrup in the form of a viscous brown opaque liquid with a fragrant smell.
1 f.

thick extract of valerian 200 mg

liquid hops cone extract 0.4 ml

liquid extract of thyme 10 ml

tincture of hawthorn (1: 5) 3 ml

tincture of mint 0.4 ml

Excipients: sorbic acid, sorbitol (60.16%), purified water.

100 ml - bottles of dark glass (1) complete with a measuring spoon - packs.

INSTRUCTION FOR THE SPECIALIST.

The product description was approved by the manufacturer for the 2009 print edition.

PHARMACHOLOGIC EFFECT

Phytomedication.
Has a sedative effect.
PHARMACOKINETICS

Data on the pharmacokinetics of the preparation Passiff are not provided.

INDICATIONS

- increased nervous excitability;

- sleep disorders.

The drug is indicated for use in adults and children over 12 years of age.

DOSING MODE

Adults and children over 12 years of age are prescribed by mouth 5 ml 2-3 times / day;
at disturbances of a dream - 5-10 ml for 30-60 mines before a dream. The course of treatment is 2-4 weeks.
If necessary, a repeat course of treatment is possible.

SIDE EFFECT

From the digestive system: rarely - nausea, vomiting.

From the side of the central nervous system: drowsiness.

Other: allergic reactions, weakness.

CONTRAINDICATIONS

- gastritis with increased secretion;

- cholelithiasis;

- children's age till 12 years;

- Pregnancy;

- the period of lactation (breastfeeding);

- Hypersensitivity to the components of the drug.

PREGNANCY AND LACTATION

The drug is contraindicated in pregnancy and during breastfeeding.

APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS

The drug is contraindicated for use in cholelithiasis.

APPLICATION FOR CHILDREN

Contraindication: children under 12 years.

SPECIAL INSTRUCTIONS

Passiffite contains sorbitol (60.16%), which should be taken into account when prescribing the drug for diabetes mellitus.

OVERDOSE

At present, no cases of an overdose of Passiffyte have been reported.

DRUG INTERACTION

With simultaneous use, it is possible to enhance the effect of drugs that depress the central nervous system (including sedatives, hypnotics), spasmolytic drugs, cardiac glycosides.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

The drug should be stored in a place protected from light, inaccessible to children at a temperature of 12 ° to 15 ° C.
Shelf life - 1 year 6 months.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!